For the first time ever, scientists have peered inside drug delivery nanoparticles with a powerful new combination of techniques — and what they found could help create safer, more effective medicines for everyone.
Drug delivery nanoparticles are tiny particles, often made from fat molecules, that act like miniature taxis. They ferry medicines through the body and drop them off exactly where they're needed — in specific organs or even certain cells. Sounds like science fiction, but this technology is already used in treatments today. The catch? Scientists need to understand exactly how these particles are built — their size, shape, and inner architecture — to make sure they're safe and work properly.
Here's the problem: previous methods only showed scientists the outside of these particles. It was like trying to understand a house by only looking at the outside walls. The inside — where the medicine actually sits — remained hidden.
That changed in Grenoble, France, at the Institut Laue-Langevin (ILL), a world-leading neutron research center. An international team of scientists from Germany, South Africa, and Sweden became the first ever to combine two powerful lab techniques: AF4 (asymmetric-flow field-flow fractionation, a particle-sorting method) with SANS (small-angle neutron scattering). The experiment happened on the ILL's D11 instrument.
Neutron scattering might sound complicated, but think of it like ultrasound for nanoparticles — a way to "see" structures too small for regular microscopes. By combining these techniques, the scientists could not only measure the particles' size and shape, but also examine how the medicine was arranged inside them.
The team tested nanoparticles designed for drug delivery, using different chemical formulas to see how changing ingredients affected the final product. They found that swapping one surfactant — a helper substance that stabilizes particles — for another could change the particle's shape, size, and internal organization entirely.
The research, published in the journal Small Methods in 2026, could make a real difference in how future medicines are developed. Understanding internal structure helps scientists design nanoparticles that carry drugs more efficiently and break down safely in the body.
International quality standards already require that nanoparticle sizes in a batch not vary by more than 30 percent to be considered safe for use. This new technique could help manufacturers meet those standards more reliably — and maybe even tighten them further as our understanding grows.
The discovery opens the door to using neutron scattering to study increasingly sophisticated drug delivery systems, potentially supporting treatments for cancer, infections, and other diseases where precision really matters.